Adjuvant Effects of Health Education of Chinese Medicine for Chronic Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Table 1

Characteristics of the 12 included trials.

Study ID	% male	Sample size	Average age (year) (range)		Treatment course (month)	Outcomes
			Intervention	Control
For patients with hypertension
Ding 2015 [18]	53.68	136	49.54 ± 5.63	50.87 ± 5.96	6	Control rate
He 2015 [19]	56.67	90	57.1 ± 11.4 (45–79)	56.8 ± 11.2 (41–80)	12	SBP/DBP, hypertension knowledge level, SF-36
Su et al. 2014 [20]	50.00	80	77.94 ± 0.53 (75–80)	76.32 ± 0.65 (74–80)	3	SBP/DBP
Wu 2013 [21]	50.00	100	75.5 ± 4.7	74.8 ± 5.3	3	Control rate, SBP/DBP, hypertension-related questionnaire, compliance of patients
Xie et al. 2016 [22]	58.50	200	59.67 ± 6.13 (45–78)	60.37 ± 5.19 (43–80)	3	SBP/DBP, control rate
Zhang 2013 [23]	62.22	90	62.4 (42–80)	65.1 (39–81)	9	SBP/DBP, control rate
For patients with diabetes
Hao and Wang 2019 [24]	67.50	80	66.1 ± 3.1 (55–79)	63.6 ± 4.2 (53–76)	NR	Fasting glucose, 2 h postprandial plasma glucose, diabetic knowledge level, SF-36
Liu et al. 2014 [25]	55.77	104	44–81		6	Fasting glucose, 2 h postprandial plasma glucose, HbA1c, compliance of patients
Shao and Han 2018 [26]	52.33	86	27–71	29–70	NR	Fasting glucose, 2 h postprandial plasma glucose, diabetic self-care activity
Shao 2018 [27]	58.89	90	53.14 ± 5.52 (38–73)	54.42 ± 5.37 (37–75)	NR	Fasting glucose, 2 h postprandial plasma glucose
Wu 2018 [28]	50.00	86	54.57 ± 3.26 (46–63)	54.68 ± 3.48 (47–64)	12	Fasting glucose, 2 h postprandial plasma glucose, diabetic self-care activity, TG, TC
For patients with coronary heart disease
Yang et al. 2015 [29]	52.46	61	58 ± 6.33 (41–73)	57 ± 7.12 (43–74)	6	SAQ, the dosage of nitroglycerin tablets

NR: not reported; SBP: systolic blood pressure level; DBP: diastolic blood pressure level; TG: total cholesterol; TC: triglyceride; SAQ: Seattle Angina Questionnaire.